Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tonix Pharmaceuticals Holding (TNXP) Total Non-Current Liabilities: 2023

  • Tonix Pharmaceuticals Holding's Total Non-Current Liabilities was N/A to $34.3 million in Q4 2023 from the same period last year, while for Dec 2023 it was $34.3 million, marking a year-over-year change of. This contributed to the annual value of $34.3 million for FY2023, which is N/A change from last year.
  • Tonix Pharmaceuticals Holding's Total Non-Current Liabilities amounted to $34.3 million in Q4 2023.
  • Tonix Pharmaceuticals Holding's 5-year Total Non-Current Liabilities high stood at $34.3 million for Q4 2023, and its period low was $34.3 million during Q4 2023.
  • For the 1-year period, Tonix Pharmaceuticals Holding's Total Non-Current Liabilities averaged around $34.3 million, with its median value being $34.3 million (2023).